Tuesday, February 26, 2019 8:28:01 AM
Vapor Group, Inc. (VPOR) Names David Zinger as President and CEO
Additional Changes To Be Announced Within Week
NEWS PROVIDED BY
Vapor Group, Inc.
Feb 26, 2019, 08:00 ET
SHARE THIS ARTICLE
MIAMI, Feb. 26, 2019 /PRNewswire/ -- Vapor Group, Inc. (OTC Pink: VPOR), ("Company" or "Vapor Group"), today announced that its Board of Directors has appointed David Zinger as President and Chief Executive Officer.
"These leadership appointments are effective immediately and follow the decision that Yaniv Nahon step down as President and Chief Executive Officer and resign as a director of the Company. Dror Svorai, Vapor Group's primary consultant, has also resigned and is no longer involved with the Company," stated Yaron Elkayam, its new Chairman of the Board of the Company.
He added, "We are fortunate to have someone of David Zinger's caliber and experience step in to lead Vapor Group. The Company is at a critical juncture and we need renewed leadership to successfully implement our strategy and take advantage of the market opportunities ahead. David is a visionary with a proven track record of execution. He is a strong communicator who is customer-focused with deep leadership capabilities."
"I couldn't be more honored to have been chosen to lead the transformation of Vapor Group," said David Zinger. "We foresee a huge opportunity ahead for VPOR, but to seize it, we must focus clearly, move fast and continue to transform and evolve the Company. A big part of my job will be to accelerate our ability to grow."
Yaron Elkayam continued, "In my opinion, during this transformative time, there is no better person to lead VPOR than David Zinger."
He added, "Separately for our shareholders, let me restate what I have said before, the changes that we are making will not include any reverse stock split, any change in name or trading symbol or change in domicile of Vapor Group. But they will represent a total shift in Vapor Group's operations and location, all of which will be evident on Vapor Group's forthcoming new website which we will have online quickly."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM